frenolicin b has been researched along with Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, BD; Cao, Y; Chaiswing, L; Chen, J; Guo, Y; Horn, J; Leggas, M; Ponomareva, LV; Shaaban, KA; She, QB; St Clair, DK; Thorson, JS; Wang, X; Wei, Q; Ye, Q; Zhang, Y; Zhu, H | 1 |
1 other study(ies) available for frenolicin b and Neoplasms
Article | Year |
---|---|
Frenolicin B Targets Peroxiredoxin 1 and Glutaredoxin 3 to Trigger ROS/4E-BP1-Mediated Antitumor Effects.
Topics: Adaptor Proteins, Signal Transducing; Animals; Antineoplastic Agents; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Glutaredoxins; Humans; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Nude; Naphthoquinones; Neoplasms; Peroxiredoxins; Phosphorylation; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Signal Transduction; Transplantation, Heterologous | 2019 |